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Malaria is one of the most prevalent vector-borne infectious diseases with major 
morbidity and mortality in sub-Saharan Africa and Southeast Asia. Recent 
epidemiological studies have shown that co-occurrence of soil-transmitted helminth 
(STH) infections, or infection caused by parasitic worms, are associated with increased 
risk of malaria infection. However, studies of the association between STH and malaria, 
and the effect of antihelminth (deworming) treatments that are more commonly used in 
areas with high STH infection rates, are sparse. Therefore, we explored the relationship 
between STH and malaria infection in an Indonesian community (N=1997) with high 
prevalence of both STH and malaria while controlling for covariates and evaluating the 
role of deworming treatment as a covariate. Participants with STH infection and/or 
malaria infection were categorized as either infected or uninfected using PCR testing 
(cycle threshold count) at both baseline and end of study. Self-report, blood, and stool 
samples were used to assess overall STH and malaria infection from September 2008 to 
July 2010. Descriptive statistics were used to assess the impact of STH infection on 
malaria outcomes. To quantify these associations, robust Poisson regression models were 
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used to assess the impact of baseline infections including STH infection on malaria while 
adjusting for age, sex, and the use of deworming treatment. Approximately 39.5% and 
19.1% of all participants were infected with Plasmodium vivax and P. falciparum, 
respectively, at the start, while 18.0% and 9.96%, respectively, were infected at the end. 
A positive association was observed between Ascaris lumbricoides and P. vivax, and 
between Necator americanus and P. falciparum (PR = 1.04, 95% CI = 0.53 to 2.04; PR = 
2.07, 95% CI = 1.00 to 4.29, respectively). While a negative association was observed 
between N. americanus and P. vivax, and between A. lumbricoides and P. falciparum (PR 
= 0.91, 95% CI = 0.44 to 1.89; PR = 0.66, 95% CI = 0.27 to 1.65, respectively). Overall, 
two of these models were significant (p = 0.062; p = 0.008; p = 0.030; p = 0.062, 
respectively). Similarly, there was a positive association observed between the use of 







TABLE OF CONTENTS 
 
Page 
ABSTRACT ……………………………………………………………………………. iv 
LIST OF TABLES …………………………………………………………………….. vii 
LIST OF FIGURES …………………………………………………………………… viii 
CHAPTER 
I. BACKGROUND AND SIGNIFICANCE ………………………………………..1 
A. Introduction …………………………………………………………………...1 
B. Physiology of the Relationship between  
STH and Malaria Infection …………………………………………………...3 
C. Epidemiology of the Relationship between  
STH and Malaria Infection …………………………………………………...5 
D. Study Objectives, Significance and Innovation ……………………………....6 
II. STUDY DESIGN AND METHODS ……………………………………………..8 
A. Study Design and Population ………………………………………………....8 
B. Exposure Assessment ………………………………………………………....9 
C. Outcome Assessment ………………………………………………………..10 
D. Covariate Assessment ……………………………………………………….11 
III. DATA ANALYSIS ……………………………………………………………...12 
A. Descriptive Analysis and analytical framework …………………………….12 
B. Bivariate Analysis …………………………………………………………...12 
C. Multivariable Analysis ………………………………………………………13 
IV. RESULTS ……………………………………………………………………….14 




LIST OF TABLES 
 
Table               Page 
 
1. Number and percent in final sample; n=1997 ………………………………….20 
2. Distribution of covariates according to Plasmodium vivax  
infection at baseline ……………………………………………………..22 
3. Distribution of covariates according to Plasmodium vivax 
  infection at end of study ...……………………………………………….23 
4.  Distribution of covariates according to Plasmodium falciparum 
  infection at baseline ……………………………………………………..24 
5. Distribution of covariates according to Plasmodium falciparum 
  infection at end of study ...……………………………………………….25 
6. Multivariable association between STH infection and  
  Plasmodium vivax infection ……………………………………………..26 
7. Multivariable association between STH infection and  





LIST OF FIGURES 
Figure                Page 
 






BACKGROUND AND SIGNIFICANCE 
 
A. Introduction 
Malaria is considered one of the most severe public health problems in the world, 
despite various prevention interventions and recommendations from health professionals 
on the benefits of using insecticide-treated bednets (ITNs), early diagnosis and treatment, 
and controlling the vectors.1 In 2019, the World Health Organization (WHO) reported 
that almost half of the world’s population lives in high risk areas for malaria with an 
estimated 229 million clinical episodes and 409,000 deaths attributable to malaria 
infections and its complications.2 Although the majority of cases are found in the African 
region, in 2019 the WHO reported an estimated 6.3 million cases in the South-East Asia 
region and approximately 9000 deaths.2 Overall, an estimated 3.4 billion people in 92 
countries are at risk of being infected and developing the disease.3 Due to an efficient 
vector transmission, an ideal environment, scarce health resources and socioeconomic 
instability, malaria is an especially prevalent disease in young children, pregnant women, 
due to incomplete immunity, and travelers.4  
In vulnerable populations, malaria is associated with a variety of symptoms that 
can range from absent/mild to life threatening disease depending on the blood stage of the 
parasite. In an uncomplicated infection, the disease may presents itself in three main 
stages, although rarely observed: a cold stage, a hot stage, and a sweating stage with 
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symptoms such as fever, chills, headaches, vomiting, and general malaise occurring every 
second or third day.5 In contrast, in a more severe infection, symptoms may include organ 
failure, severe anemia, acute respiratory distress syndrome, and abnormalities in blood 
coagulation.4  
These incidence rates can increase depending on region, average environmental 
temperature, vector reproduction, and medical access. Individuals who reside in warmer 
areas with humid climates that have high population of Anopheles mosquitos (the vector 
for malaria), are at higher risk of becoming infected with malaria.6 Additionally, if the 
mosquitos are able to live longer and infect more people, then those within that region are 
also at higher risk. Other modifiable risk factors include having access to medical 
attention and preventative tools such as insecticide-treated bednets and indoor insecticide 
treatments (IRS). Without these preventative strategies, the risk of being infected 
increases and not getting immediate medical attention increases the likelihood of death 
due to malaria infection.6 Therefore, the ability to access these resources over time is a 
useful predictor of health risk. 
Malaria, however, is not the only vector-borne disease that is common in specific 
regions and climates. Soil-transmitted helminths (STH) are parasitic worms that favor 
similar conditions to malaria and its vector, and are found in some of the most popular 
malaria infected spots such as Sub-Saharan Africa and Southeast Asia.7 Similarly to 
malaria cases, more than 1.5 billion people have been infected with STH worldwide, with 
over 500 million of those infected being school-age children.7 More specifically, 
according to the US Center for Disease Control and Prevention department, over an 
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estimated 1.1 billion cases were seen in 2013 within the African and Southeast Asian 
regions.8 Due to similar geographic ranges, and impacted populations, several studies 
have investigated the relationships between malaria and STH.  
Similarly, to malaria, STH infections are associated with immunocompromising 
symptoms that can range from mild to life-threatening depending on infection intensity, 
(the number of parasitic worms present in an individual). In a more intense infection, the 
most common symptoms that are present are diarrhea, abdominal pain, nutrient 
deficiency, general weakness, and impaired growth and physical development.7 In 
extreme cases, an infection of very high intensity could present symptoms like intestinal 
obstruction, requiring special surgical procedures to resolve.7 With significant infection 
prevalence in communities, and with similar risk factors, this study therefore proposes a 
secondary analysis of data from a randomized control trial (RCT) to examine the 
relationship between STH, measured by PCR-based cycle threshold count (Ct) and 
malaria infection, as indicated by Ct of parasitemia, among a cohort of Indonesian 
household members using data collected between September 2008 and July 2010. 
 
B. Physiology of the Relationship between STH and Malaria Infection 
Malaria and STH are caused by two different groups of parasites, a Plasmodium 
spp. microorganism and either hookworm species or Ascaris species parasitic worms, 
respectively.9–11 In general, both parasites require a human host in order to continue their 
life cycle, however, the way in which they do so is fairly different. In terms of malaria, 
Plasmodium spp. require transportation from a vector, more specifically a female 
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Anopheles mosquito, to penetrate into a human host’s liver through the blood, and then 
later on, to the bloodstream.7 Once inside the host, Plasmodium parasites are able to 
multiply and prepare for the next transmission to occur through a different Anopheles 
mosquito. In contrast, in terms of STH, helminths do not require a vector but do require a 
human host and access to feces. The eggs of the helminths are fertilized in feces that later 
are deposited on soil which allows the eggs to hatch larvae.10,11 Once in the larval stage, 
humans must come into contact with the helminths either through the touch of the 
infected soil or through ingestion of larvae in order to become infected.10,11 Once 
infected, and depending on the specific helminth, the human host begins to show 
symptoms and increase parasitic density. Although these parasites have very different life 
cycles and transmissions, these two infections may impact the host’s immune system in a 
similar way, lowering the host’s defenses and reproducing at a fast rate causing major 
clinical impacts. In addition, it has been found that STH infections causes an immune 
response in the host that suppresses T-cell activity, or a body’s ability to respond to 
infection quickly, and renders the host more susceptible to other co-infections.12  
Due to such an impactful effect of infection, and the fact that co-infections are 
common, it has been hypothesized that when one infection occurs, the human host may 
be more susceptible to another infection at the same time or later in life due to an 
impaired ability to react to subsequent infection.13 As a result, communities are 
attempting to keep up with these co-infections by providing specific treatments that 
mainly target the controllable infection such as STH and are readily accessible. 7,14 These 
types of treatments are called antihelminth treatments, with albendazole being the most 
common. By providing a treatment that focuses on reducing the density and burden of 
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STH, it may influence how the host is able to fight off the remaining malaria infection, 
impacting the host’s chances of better clinical outcomes from a co-infection.   
 
C. Epidemiology of the Relationship between STH and Malaria Infection 
Five epidemiologic studies have evaluated the co-infection between STH and 
malaria, all of which are cross-sectional in design.15–19 Of these studies, two studies took 
place in West Africa (Ghana, and Nigeria),16,17 two in Central Africa (Gabon and 
Cameroon),15,19 and one in Ethiopia.18 Age ranges were 0-15 years in two studies,15,19 0-
100 years in one study,16 0-40 years in one study,17 and 15-45 years in one study.18 In all 
the studies, information was collected via questionnaires, along with both blood samples 
(both thick and thin sample slides) and stool samples,15–19 In terms of the outcome, all the 
studies evaluated helminth and malaria as a co-infection, while three studies also looked 
at helminth and malaria infection individually.15,16,18 Overall, all the studies included age, 
sex, and socioeconomic status as covariates.14-18  Three studies found a positive 
association between helminth and odds of malaria infection,17–19 one study was null,16 
and one found an inverse association.15 In terms of a possible confounding, only two 
studies considered deworming treatment having an effect on infection,16,19 with one 
finding evidence for a positive association.19  
In the only study that yielded a positive association when considering a 
deworming treatment, Ndamukong-Nyanga et al. conducted a cross-sectional survey that 
involved 1138 school-aged children in Southwest Cameroon.19 Participants consisted of 
children of both sexes between the ages of 4 and 15 years who had been enrolled in one 
of the study schools that had received parental/guardian consent between 2012 and 2014. 
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Questionnaires, fever assessment, blood, and stool samples were collected from eligible 
participants. Additionally, all individuals that were positive for either malaria or STH 
infection received free malarial and deworming treatments as part of a community 
prevention program. Overall prevalence for individual malaria and helminth infection 
was 38% and 2.5% respectively, however, prevalence for co-infection was significantly 
lower ranging from 2.6% to 0.2% depending on the location of the schools. 
In summary, all five epidemiological studies were limited in regard to study 
design and sample size, all with a cross-sectional design and only two studies with a 
sample size larger than 1000 people,16,19 and all of the studies were conducted in Africa. 
Out of the two studies taking into consideration deworming treatment, neither of which 
assessed it as a covariate, rather just focused on the infections overall.   
D. Study Objectives, Significance and Innovation 
This study proposes to assess the relationship between STH infection, and risk of 
malaria, both measured by disease infection in Indonesian communities adjusting for age, 
sex, and use of deworming treatment. Specifically, the aim of the study is: 
 
Specific Aim: Use data collected from household surveys in Indonesian 
villages to evaluate the relationship between STH infection and risk of 
malaria. 
 
Hypothesis 1: People with a positive STH infection will have a higher risk 
for malaria co-infection, as compared to people who are negative for STH 
infection. 
 7 
   
This investigation will contribute to the sparse epidemiological literature on the 
association between STH and malaria infection among Indonesian communities.  
This proposal is innovative in being one of the few to study the relationship 
between STH infection and risk of malaria infection in Indonesia as opposed to Sub-
Saharan Africa, focusing on helminth co-infection affecting risk of malaria. It is also 
innovative in its power to control for covariates and ability to evaluate the role of 
albendazole treatment as a covariate.  
This study is significant because co-infection rates and the use of deworming 
treatments are rapidly growing in places like Africa and Southeast Asia. Few studies have 
looked at the association between STH and malaria infection among Southeast Asian 
regions, and this study can contribute to a more comprehensive understanding of this 




STUDY DESIGN AND METHODS 
 
A. Study Design and Population 
            We evaluated the relationship between STH and malaria infection in Indonesian 
communities using data from the Resource Competition study: an ecological study 
conducted between September 2008 and July 2010.13 Adult and children community 
members were randomly enrolled from Indonesian village households and were all 
initially considered as potential participants for this study. Household members were 
eligible to participate if they were adult males, females and children. These households 
were located within the Ende district of Flores Island, Indonesia with a focus on 
communities within Nangapanda. This particular area was chosen by the investigators 
due to a high prevalence for malaria and being a high endemic area for STH.20 All 
individuals within a household were considered eligible. The exclusion criteria were: 1) 
pregnant women, 2) children younger than 2 years of age, and 3) persons with illness.14  
This left 3,491 individuals out of 4,650 eligible for this study. Of these 3,491 participants 
included in the dataset, 1,494 participants were excluded due to missing data. This 
resulted in a final analytic population of 1,997 participants. 
 Clinical and demographic data, stool samples for STH infection and blood 
samples for malaria infection analyses were collected from the enrolled household 
participants at baseline, at 9 months, and at 21 months follow-ups.  
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 Ethics: This secondary analysis used data collected with approvals by the Ethical 
Committee of the Medical Faculty, University of Indonesia approved the overall study 
protocol after institutional review (ethical clearance ref; 194/PT02.FK/Etik/2006), with 
fully informed written consent from participants or from parents/guardians of children.14  
 
B. Exposure Assessment 
Overall STH infection status was obtained using a questionnaire at baseline and 
two years after the treatment. Stool samples were collected every year during the study 
period from participants in order to obtain STH infection cycle threshold count (Ct). For 
the purpose of this analysis, two dichotomous categorical variables were created using Ct 
for both Necator americanus and Ascaris lumbricoides, as these are the most common 
STH species found in this region of Indonesia. These variables were categorized as either 
“uninfected” or “infected” by taking into account that the lower the Ct detected, the 
higher the infection density within the individual. Any samples that failed to amplify by 
50 Ct were automatically considered uninfected and those that were amplified below 50 
Ct were considered infected.13    
 STH infection status was cross-checked with the information obtained from 
puskesmas (government-administered community health clinics) and a research team in 
Jakarta at the Department of Parasitology, University of Indonesia.14 Additionally, 
specific helminth DNA was extracted from feces and analyzed using validated laboratory 
protocol and each sample was tested using real-time Polymerase Chain Reaction (PCR) 
to obtain accurate readings from the samples collected and a proper Ct. This specific test 
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was chosen to determine standard measures because PCR is the most accurate method of 
determining parasitic density as it correlates with visual fecal egg counts, which is a more 
traditional way of detecting and counting soil-transmitted helminths.13 
 
C. Outcome Assessment 
 To obtain information on malaria status, the same questionnaire mentioned above 
was used. Follow-up questionnaires regarding general health and malaria related health 
concerns were given to each household every month. The survey questions assessed 
respondents had medically diagnosed malaria or if they show any malaria related 
symptoms. In this case, malaria symptoms are defined as fever (oral temperature greater 
than 37.5°C) and/or history of fever within 48 hours. In addition to malaria infection 
status, infection density was also obtained by collecting peripheral blood samples on 
randomly selected individuals over four years of age within each household at baseline, 
12 months, and 24 months follow-up. Additionally, to properly assess the whole study 
population, those that were not chosen for venous blood collection had their finger 
pricked to evaluate malaria status. These samples were used to determine Ct of three 
species: Plasmodium falciparum, P. malariae, and P. vivax and used to determine the 
overall infection status of an individual. Any samples that failed to amplify by 50 Ct were 
considered uninfected.13 For the purpose of this analysis, two dichotomous variables were 
created using Ct for both Plasmodium falciparum and P. vivax, as these are the most 
common malaria species in the Indonesia. These variables were categorized as either 
“uninfected” or “infected”.  
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 To assess validity of the malaria Ct, the reported values were cross-checked with 
the official community records mentioned above in the assessment of exposure and 
through proper laboratory procedures. These procedures consisted of using the blood 
samples collected and extracting them for DNA to test against specific polymers using 
multiplex PCR. The polymers selected are specifically used to detect some of the main 
human-infecting malaria pathogens (P. falciparum, P. vivax, and P. malariae).13 
Additionally, blood smears were also assessed using a laboratory protocol Giemsa stain 
and examined by expert microscopists.10  
 
D. Covariate Assessment 
 Risk factors associated with both STH and malaria infection were assessed as 
possible confounders. These covariates included: age (in years), sex of individuals (male 
or female), and use of deworming treatment at baseline and end of study period.13 They 
were abstracted from clinical records and questionnaires administered at baseline and 
monthly follow-ups. These were used to control for confounding in the potential 
relationship between co-infection of STH and malaria. To use deworming treatment as a 





Specific Aim: Use data collected from households in Indonesian villages to evaluate the 
relationship between STH infection and risk of malaria. 
 
 All statistical analyses were conducted using RStudio version 1.2.5033. 
Modification such as creating new variables were made to account for STH and malaria 
infection outcome measures and missing data among the covariates. This modified 
dataset was only used for multivariable model building.  
 
A. Descriptive Analysis 
 The total study population and the percent of participants who did not have a STH 
or malaria infection, as well as the number and percent of those missing data were 
assessed. The total number and percentage of those with STH or malaria infection was 
also calculated. The mean and SD of those with and without malaria infection were 
calculated for both baseline and end of study period time points.  
 
B. Bivariate Analysis 
The prevalence of STH and malaria infections were compared in regard to study 
population characteristics chi-square (X2) tests and Fisher’s exact tests for small cell 
frequencies. ANOVA was used to obtain p-values for continuous covariates. 
 
C. Multivariable Analysis 
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 Robust Poisson regression modeling was used to assess the relationship between 
STH and malaria infection. Separate models were made for each STH and malaria 
pathogen species at both baseline and end of study period. Covariates that caused a 10% 
change in the coefficient for STH infection was considered a confounding factor and 
included in all the final models. Prevalence ratios and 95% confidence intervals were 





 The final dataset consisted of 1,997 participants, as can be seen in Table 1. Of the 
1,997 participants included in this analysis, 789 (39.5%) were infected with N. 
americanus at baseline and 359 (18.0%) at the end of follow-up, while 382 (19.1%) were 
infected with A. lumbricoides at baseline and 199 (9.96%) at the end of the study period. 
The mean age (SD) of participants infected with N. americanus and A. lumbricoides at 
baseline was 33.2 (19.3) and 26.5 (18.7) respectively (t-test: p = 0.049 and <0.001), while 
the mean age (SD) of participants infected with N. americanus and A. lumbricoides at the 
end of follow-up was 35.2 (20.1) and 27.5 (20.1) respectively (t-test for difference:  p = 
0.0011, and 0.0702 respectively). The proportion of females infected was higher in those 
infected with either N. americanus or A. lumbricoides at both baseline and end of study 
(58.7%, 42.6%, and 61.3%, 65.3% respectively) as seen in Figure 1, although this 
difference was not statistically significant (X2 test: p = 0.629; 0.405; 0.396; and 0.07 
respectively). A similar and not statistically significant increase was observed in 
participants who were treated with albendazole and were infected with N. americanus 
(0% vs 21.2%) or A. lumbricoides (0% vs 22.6%) at the end of the study when compared 
to the baseline (X2 test: p = 0.737 and 0.779 respectively).  
 Results from P. vivax and P. falciparum infections are presented in Tables 2, 3, 4, 
and 5. Of the 1,997 participants, 122 (6.11%) were infected with P. vivax at baseline and 
40 (2%) at the end of study, while 138 (6.91%) were infected with P. falciparum at 
baseline and 39 (1.95%) at the end of study. There was a slight increase in the number of 
males (50.8%) that were infected with P. vivax at baseline, with an inverse situation of 
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more females (60%) infected at end of study. On the contrary, more females were more 
likely to be infected with P. falciparum at both baseline and the end of study (58.7% and 
66.7% respectively) as seen in Tables 4 and 5. The mean age (SD) of those infected with 
P. vivax at baseline and end of study was 24.1 (16.4) and 24.8 (18.3). Similarly, the mean 
age (SD) of those infected with P. falciparum at baseline and end of study was 23.2 
(16.5) and 28.8 (18.8) respectively (Tables 2, 3, 4, and 5). In general, the number and 
percent of participants between 23 – 33 years of age that were infected with a 
Plasmodium spp. was greater at baseline than participants infected at the end of study of 
the study. Overall, there was significant increase in participants that received albendazole 
treatment and were found to be infected with either P. vivax (0% vs 47.5%) or P. 
falciparum (0% vs 53.8%) at the end of study when compared to those infected at 
baseline (p = <0.001).   
 Tables 6 and 7 shows the associations between dichotomized STH infection and 
P. vivax and P. falciparum infection. We observed a nonsignificant increase in the co-
infection between P. falciparum and N. americanus in an unadjusted model but observed 
a significant increase in the adjusted model (PR = 1.13, 95% CI = 0.60 to 2.11, p = 0.711; 
PR = 2.07, 95% CI = 1.00 to 4.29, p = 0.01, respectively). Similarly, we also observed a 
small nonsignificant increase in P. vivax infection among participants infected with A. 
lumbricoides as compared to those not infected in both the unadjusted and adjusted 
model (PR = 0.97, 95% CI = 0.49 to 1.93, p = 0.932; PR = 1.04, 95% CI = 0.53 to 2.04, p 
= 0.912, respectively). On the contrary, we observed a nonsignificant decrease in P.vivax 
infection among participants infected with N. americanus, as well as in P. falciparum 
infection among those infected with A. lumbricoides as compared to those not infected in 
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both the unadjusted and adjusted models (PR = 0.64, 95% CI = 0.34 to 1.20, p = 0.165; 
PR = 0.91, 95% CI = 0.44 to 1.89, p = 0.802; PR = 0.56, 95% CI = 0.25 to 1.26, p = 
0.162, respectively). However, in the adjusted model for P. falciparum infection among 
those infected with A. lumbricoides, there was a significant decrease observed (PR = 
0.66, 95% CI = 0.27 to 1.65, p = 0.030). Furthermore, we observed some non-statistically 
significant collinearities between STH and malaria infection at baseline and P. vivax at 
the end of study in an adjusted robust Poisson regression model (PR = 0.11, p = 0.8272), 
as well as a slightly positive increase in mean age and a decrease in female participants 
that were infected with P. vivax when compared to those not infected (PR = 1.00, 95% CI 
= 0.97 to 1.02; PR = 0.69, 95% CI = 0.25 to 1.87, respectively), although these 





 In this secondary analysis of a randomized control trial of STH and malaria co-
infection in Indonesia, we observed both positive and negative associations between both 
STH infections and malaria parasitemia as measured by PCR. More specifically, we 
observed an overall decrease in participants infected with either P. vivax or P. falciparum 
at baseline and end of study when compared with those not infected. In other words, as 
STH infections were decreasing from baseline to end of study, malaria infections were 
also decreasing at those time points. In addition, we observed an increase in females 
being infected from baseline to end of study when compared to males being infected. 
Although statistical significant effects were not found with sex and were found with co-
infection, these results are consistent with previous literature17–19 and suggest potential 
for decreased malaria infection among those with STH infection. Interestingly, a positive 
association was also observed between the use of albendazole treatment and both STH 
and malaria infections, especially between N. americanus and P. falciparum. However, 
even though overall STH and malaria infections decreased between baseline and end of 
study, we observed an increase in the number of participants with malaria infections at 
the end of study that were treated with albendazole compared to the number of 
participants with malaria infection at baseline who received albendazole treatment, which 
is a similar result that a previous study had observed,16 although only a few 
epidemiological studies have assessed the role deworming treatments may have on 
immune responses. 
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This study is not without limitations. One important limitation is loss to follow-up, 
since participant information was obtained from voluntary questionnaires. It is possible 
that individuals that developed less severe symptoms or were asymptomatic classified 
themselves as not infected with either STH or malaria. These individuals could have been 
less concerned about the outcome of the study as they might have seen it as time-
consuming or a burden to participate in. In addition, it is possible that individuals might 
have not had the resources to participate for longer periods of time and therefore decide 
to leave the study early. This form of differential loss to follow-up would result in an 
attenuation of any measure association. 
 Non-differential misclassification of malaria outcome could have also occurred in 
our study, resulting in an underestimation of the association between STH and malaria 
infection. Participants were considered uninfected if samples failed to amplify by 50 Ct.  
Therefore, if a participant had provided samples during the incubation period, it would 
have been missed by the PCR. Since STH infection was also established using the same 
cut off Ct, this could have also misclassified participants in our study.  
Regardless of the potential limitations, our study has several strengths. The 
prospective study design and collection of data at multiple time points limit the potential 
for temporal bias or recall bias which are common in other study designs that are used in 
previous literature. Our ability to adjust for covariates and evaluate the role of 
albendazole treatment as a covariate makes our study unique from other studies that also 
evaluated STH and malaria infection. Our study population was also a high-risk, but 
under-studied cohort of people in a community in Flores, Indonesia.   
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Overall, the present study found that those infected with P. vivax are negatively 
associated to those with an initial A. lumbricoides infection but positively associated to 
those with an initial N. americanus infection, while individuals infected with P. 
falciparum are positively associated to those with an initial N. americanus infection and 
negatively associated to those with an initial A. lumbricoides infection. Therefore, 
depending on the specific malaria infection, individuals can be more at risk of co-
infection than those without an initial STH infection. This study provides preliminary 
results that lay the foundation for future studies assessing the association between STH 
and malaria infection among Indonesian communities. Further studies evaluating 
albendazole treatment as either an effect modifier or potential exposure to co-infection 
are warranted and will help explain the impact of co-infection has on communities at high 
risk such as Indonesia.     
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Table 1. Number and percent in final sample; n=1997 
    Total Percent 
Original Study Sample  10,473 100% 
    
Excluded 
Pregnant women, 
children younger than 
2 years, ill persons 
3,491 33.33% 
 Missing Data 1,494 14.26% 
    









Figure 1. Malaria infection by sex  
P.vivax/P.fal @ baseline = Plasmodium vivax/Plasmodium falciparum 
infection status at baseline; P.vivax/P.fal @ end = Plasmodium 
vivax/Plasmodium falciparum infection status at end of study. 
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Table 2. Distribution of covariates according to Plasmodium vivax infection at baseline 
 Malaria Status  
 uninfected infected Total 
p-value  (N=1875) (N=122) (N=1997) 
Sex     
Male 750 (40.0%) 62 (50.8%) 812 (40.7%) 0.01853 
Female 1125 (60.0%) 60 (49.2%) 1185 (59.3%)  
     
Age (in years)     










     
Albendazole 
Treatment 
    
No 1439 (76.7%) 122 (100%) 1561 (78.2%) <0.0001 






Table 3. Distribution of covariates according to Plasmodium vivax infection at end of 
study 
 Malaria Status  
 uninfected infected Total 
p-value  (N=1957) (N=40) (N=1997) 
Sex     
Male 796 (40.7%) 16 (40.0%) 812 (40.7%) 0.9315 
Female 1161 (59.3%) 24 (60.0%) 1185 (59.3%)  
     
Age (in years)     










     
Albendazole 
Treatment 
    
No 1540 (78.7%) 21 (52.5%) 1561 (78.2%) <0.0001 










 uninfected infected Total 
p-value  (N=1859) (N=138) (N=1997) 
Sex     
Male 755 (40.6%) 57 (41.3%) 812 (40.7%) 0.8733 
Female 1104 (59.4%) 81 (58.7%) 1185 (59.3%)  
 
    
Age (in years)     











    
Albendazole 
Treatment 
    
No 1423 (76.5%) 138 (100%) 1561 (78.2%) <0.0001 









Table 5. Distribution of covariates according to Plasmodium falciparum infection at 




 uninfected infected Total 
p-value  (N=1958) (N=39) (N=1997) 
Sex     
Male 799 (40.8%) 13 (33.3%) 812 (40.7%) 0.347 
Female 1159 (59.2%) 26 (66.7%) 1185 (59.3%)  
 
    
Age (in years)     
Mean (SD) 32.1 (19.8) 28.8 (18.8) 32.1 (19.7) 0.2677 
Median [Min, 







    
Albendazole 
Treatment 
    
No 1543 (78.8%) 18 (46.2%) 1561 (78.2%) <0.0001 
Yes 415 (21.2%) 21 (53.8%) 436 (21.8%)   
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Table 6. Multivariable association between baseline STH infection and 
Plasmodium vivax infection outcome 
 Unadjusted Adjusted 
 PR 95% CI PR 95% CI 
N. americanus     
Uninfected - Referent - Referent 
Infected 0.64 (0.34, 1.20) 0.91 (0.44, 1.89) 
          
A. lumbricoides     
Uninfected - Referent - Referent 
Infected 0.97 (0.49, 1.93) 1.04 (0.53, 2.04) 
Adjusted for age, sex, and deworming treatment. *p<0.05, **p<0.01 
STH = Soil-Transmitted Helminths 
The variable for soil-transmitted helminth infection was observed at baseline and the 





Table 7. Multivariate association between baseline STH infection and 
Plasmodium falciparum infection outcome 
 Unadjusted Adjusted 
 PR 95% CI PR 95% CI 
N. americanus     
Uninfected - Referent - Referent 
Infected 1.13 (0.60, 2.11) 2.07 (1.00, 4.29)** 
          
A. lumbricoides     
Uninfected - Referent - Referent 
Infected 0.56 (0.25, 1.26) 0.66 (0.27, 1.65)* 
          
Adjusted for age, sex, and deworming treatment. *p<0.05, **p<0.01 
STH = Soil-Transmitted Helminths 
The variable for soil-transmitted helminth infection was observed at baseline and the 
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